ANALYSIS OF FORENSIC SPECIMENS FOR CANNABINOIDS .2. RELATIONSHIP BETWEEN BLOOD DELTA-9-TETRAHYDROCANNABINOL AND BLOOD AND URINE 11-NOR-DELTA-9-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID CONCENTRATIONS

被引:11
作者
MOODY, DE
MONTI, KM
CROUCH, DJ
机构
[1] Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT
关键词
D O I
10.1093/jat/16.5.302
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Data from five years of gas chromatographic/mass spectrometric (GC/MS) quantitation of blood, or blood and matched (i.e. concurrently collected) urine specimens, for cannabinoids have been used for two distinct evaluations. In the present study, we assessed the relationship of blood ∆9-tetrahydrocannabinol (THC) with blood and urine 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid (COOH-THC) concentrations. Cannabinoid-containing (i.e. positive) forensic blood specimens (298, 135 with matched urines) were used to test for correlations and other relationships between these analytes. No correlation was found between blood THC and blood or urine COOH-THC concentrations. Significant correlations were found between the log blood and log urine COOH-THC concentration (r= 0.65). The correlations, however, were neither high nor consistent enough to suggest their use in extrapolations of urine to blood concentrations. Others have suggested that a urine COOH-THC concentration in excess of 100 ng/mL may indicate impairment. We observed this would result in 17% of individuals with blood THC less than 1 ng/mL being classified as impaired. The rate of inaccurate interpretations would increase if higher concentrations of blood THC were considered characteristic of impairment. It has been suggested that a ratio of blood COOH-THC/THC less than 4:1 is an indicator of impairment. In this study, the percentage of bloods with a ratio less than 4:1 increased as THC concentrations increased. However, THC concentrations in excess of 10 ng/mL were required before a majority (70%) of the specimens fell below this ratio, suggesting limitations to its use. Blood metabolic ratios (THC/COOH-THC) displayed a biomodal distribution. Because of a lack of control over the time of collection and dose of cannabis used, these data can only be considered suggestive of substantive interindividual variations in the metabolism of THC. These data confirm previous observations that interindividual variation in the metabolism and excretion of THC precludes accurate estimates of the parent drug when only the metabolite concentration is known. © 1992, Oxford University Press. All rights reserved.
引用
收藏
页码:302 / 306
页数:5
相关论文
共 27 条
[1]  
AGURELL S, 1986, PHARMACOL REV, V38, P21
[2]  
BARNETT G, 1989, ADV ANAL TOXICOLOGY, V2, P218
[3]  
Barnett G., 1989, COCAINE MARIJUANA DE, P113
[4]  
BORNHEIM LM, 1991, MOL PHARMACOL, V40, P228
[5]   GENETIC-POLYMORPHISM OF HUMAN-LIVER ALCOHOL AND ALDEHYDE DEHYDROGENASES, AND THEIR RELATIONSHIP TO ALCOHOL METABOLISM AND ALCOHOLISM [J].
BOSRON, WF ;
LI, TK .
HEPATOLOGY, 1986, 6 (03) :502-510
[6]   HYDROXYLATION OF TRANS-DELTA-1-TETRAHYDROCANNABINOL BY HEPATIC MICROSOMAL OXYGENASE [J].
BURSTEIN, S ;
KUPFER, D .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 191 (DEC31) :61-&
[7]   QUANTITATIVE MEASUREMENT OF DELTA-9-TETRAHYDROCANNABINOL AND 2 MAJOR METABOLITES IN PHYSIOLOGICAL SPECIMENS USING CAPILLARY COLUMN GAS-CHROMATOGRAPHY NEGATIVE-ION CHEMICAL IONIZATION MASS-SPECTROMETRY [J].
FOLTZ, RL ;
MCGINNIS, KM ;
CHINN, DM .
BIOMEDICAL MASS SPECTROMETRY, 1983, 10 (05) :316-323
[8]  
GARRIOTT JC, 1986, J FORENSIC SCI, V31, P1274
[9]  
GUENGERICH FP, 1989, ANNU REV PHARMACOL, V29, P241
[10]   COMPARISON OF H-3-LABELED RADIOIMMUNOASSAY AND I-125-LABELED RADIOIMMUNOASSAY AND GAS CHROMATOGRAPHY/MASS SPECTROMETRY FOR THE DETERMINATION OF DELTA-9-TETRAHYDROCANNABINOL AND CANNABINOIDS IN BLOOD AND SERUM [J].
HANSON, VW ;
BUONARATI, MH ;
BASELT, RC ;
WADE, NA ;
YEP, C ;
BIASOTTI, AA ;
REEVE, VC ;
WONG, AS ;
ORBANOWSKY, MW .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1983, 7 (02) :96-102